PharmaCielo Ltd. (TSXV:PCLO)

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Engaged in The Growth, Cultivation and Development of Medicinal Cannabis	2536235.00%	3173318.00%	3479797.00%	1541749.00%	5308517.00%
Total	2.54M	3.17M	3.48M	1.54M	5.31M

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Americas	2.12M	1.58M	1.58M	1.32M	4.96M
Australia	370.41K	635.02K	701.12K	130.33K	-
Europe	44.20K	179.19K	226.21K	54.07K	349.84K
Africa	-	782.69K	977.04K	41.54K	-
Total	2.54M	3.17M	3.48M	1.54M	5.31M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error